Login to Your Account



Pharmexa Seeks DKK209M In Discounted Rights Issue

By Cormac Sheridan


Wednesday, April 21, 2004
Faced with a looming cash crisis, Pharmexa A/S priced a long-expected rights issue. The Hørsholm, Denmark-based immunotherapy firm said it would offer shareholders up to about 12.3 million new shares at DKK17 per share, almost 50 percent below Monday's closing share price of DKK31.70. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription